Michael Wanner
Directeur/Membre du Conseil chez PlantForm Corp.
Profil
Michael E.
Wanner currently works at PlantForm Corp., as Director from 2022.
Mr. Wanner also formerly worked at Abeome Corp., as President & Chief Executive Officer, Oncose, Inc., as President & Chief Executive Officer, Medicago, Inc., as Executive Vice President-Operations, ProLinia, Inc., as President, and Merial, Inc., as Chief Financial Officer.
Postes actifs de Michael Wanner
| Sociétés | Poste | Début |
|---|---|---|
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Michael Wanner
| Sociétés | Poste | Fin |
|---|---|---|
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Directeur Financier/CFO | - |
Oncose, Inc.
 Oncose, Inc. Medical SpecialtiesHealth Technology Oncose, Inc. provided cancer detection, diagnosis and treatment services, using proprietary technology to detect structural changes in glycoproteins that occur during oncogenesis. The company was headquartered in Athens, GA. | President | - |
Merial, Inc.
 Merial, Inc. Pharmaceuticals: MajorHealth Technology Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA. | Directeur Financier/CFO | - |
ProLinia, Inc.
 ProLinia, Inc. Agricultural Commodities/MillingProcess Industries ProLinia, Inc. provides cloning and breeding services to the livestock industry. The company is based in Athens, GA. ProLinia was acquired by ViaGen, Inc. on June 30, 2003. | President | - |
Abeome Corp.
 Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
Abeome Corp.
Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Health Technology |
ProLinia, Inc.
ProLinia, Inc. Agricultural Commodities/MillingProcess Industries ProLinia, Inc. provides cloning and breeding services to the livestock industry. The company is based in Athens, GA. ProLinia was acquired by ViaGen, Inc. on June 30, 2003. | Process Industries |
Merial, Inc.
Merial, Inc. Pharmaceuticals: MajorHealth Technology Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA. | Health Technology |
Oncose, Inc.
Oncose, Inc. Medical SpecialtiesHealth Technology Oncose, Inc. provided cancer detection, diagnosis and treatment services, using proprietary technology to detect structural changes in glycoproteins that occur during oncogenesis. The company was headquartered in Athens, GA. | Health Technology |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |